After graduating from Maryland, Mark has been fascinated with process management and bootstrapping of businesses in any vertical.
Chief principal Erik Wagner is a biochemist with over two decades of experience in assay development, cloning, and drug development who
has since 1991, worked in drug development and managed research teams for
Uni-Gene, Wyeth/AHP, Pfizer, Meso-Scale Diagnostics, Covance, and the
National Institute of Health - Center for Advancing Translational Sciences.
Kenneth is a partner who has founded multiple startups in the American Bioscience arena and helps partner-building and development.